MAP4K4 Inhibitors
Loading...
Embargo End Date
ICR Authors
Authors
Newton, G
Schneider, M
Schneider, M
Document Type
Patent
Date
2020-06-11
Date Accepted
Abstract
This invention relates to compounds that may be useful as inhibitors of Mitogen-activated Protein Kinase Kinase Kinase Kinase-4 (MAP4K4). The invention also relates to the use of these compounds, for example in a method of treatmentof cardiac conditions.In particular, the present invention relates to compounds of formula (I):
Citation
2020
DOI
Rights
Source Title
Publisher
ISSN
eISSN
Collections
Research Team
Medicinal Chemistry 3